m6A Modification-Association with Oxidative Stress and Implications on Eye Diseases

Area of Science:

• Ophthalmology
• Molecular Biology
• Biochemistry

Background:

• Oxidative stress (OS) is an imbalance between oxidation and antioxidation, linked to aging and diseases.
• The eyes, with high oxygen consumption and UV exposure, are susceptible to OS, leading to conditions like cataracts and glaucoma.
• N6-methyladenosine (m6A) modification is a key RNA regulatory mechanism involved in various cellular processes.

Purpose of the Study:

• To review the role of m6A modification in oxidative stress-induced eye diseases.
• To explore therapeutic strategies targeting m6A in these conditions.
• To provide a comprehensive understanding of m6A's involvement in OS-related ocular pathologies.

Main Methods:

• Literature review of studies on oxidative stress and eye diseases.
• Analysis of research on m6A modification in cellular biology.
• Synthesis of findings linking m6A to OS-induced ocular conditions and treatments.

Main Results:

• m6A modification plays a significant role in the pathogenesis of oxidative stress-related eye diseases.
• Dysregulation of m6A pathways contributes to the development and progression of conditions like cataracts and glaucoma.
• Emerging therapeutic approaches targeting m6A show promise for treating these eye diseases.

Conclusions:

• m6A modification is a critical factor in oxidative stress-induced eye diseases.
• Understanding m6A's role offers new avenues for therapeutic interventions.
• Further research into m6A modulation could lead to novel treatments for preventing and managing ocular diseases.